CSI Market
Sign In | Register

Satellos Bioscience Inc (MSLE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MSLE Annual Balance Sheets →
Examining balance sheet movements between Satellos Bioscience Inc and Dec 31 2024 reveals how Dec 31 2025 adjusts its asset composition and liability profile.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents9.80
Cash & Short-term Investments9.00
Other Current Assets22.08
Total Current Assets31.88
Equipment/Property/Plant Net0.01
Total Assets31.89
Liabilities
Accounts Payable4.11
Financial Instruments0.07
Total Current Liabilities4.11
Total Long-term Debt0.00
Total Liabilities4.11
Stockholders' Equity
Other Equity27.78
Common Stockholder's Equity27.78
Total Stockholder's Equity27.78
Liabilities & Stockholder's Equity31.89
4 historic quarters locked

Sign in to unlock the full Satellos Bioscience Inc balance sheet history.

Sign In Create Free Account

About Satellos Bioscience Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 40-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-035729

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License